Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 15 EP applications Valérie Marie-Noëlle Meyrial has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11799104

ANTI-IL-18 ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/24
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842005

REGIMENS FOR TREATMENTS USING ANTI-IGF ANTIBODIES

IPC classification:
C12P 21/08, A61K 39/00, C07K 16/22, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830128

METHODS FOR PROCESSING COAGULATION FACTORS

IPC classification:
C12P 21/02
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12847479

COMBINATION THERAPIES USING ANTI- PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

IPC classification:
A61K 39/395, A61K 39/00, C12P 21/08, C07K 16/00
Applicant:
MedImmune Limited
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP13772497

DEVICES HAVING THERMOCHROMIC RESPONSE INDICATORS

IPC classification:
A61M 5/50, A61J 1/18
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP13848584

STABLE, LOW VISCOSITY ANTIBODY FORMULATION

IPC classification:
A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14782188

VACCINE COMPOSITION AND METHOD OF USE

IPC classification:
A61K 39/39
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP14818351

SEPARATION OF RECOMBINANT POLYCLONAL ANTIBODY MULTIMERS WITH MINIMAL SEPARATION OF MONOMERS

IPC classification:
C07K 16/00
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15740660

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG

IPC classification:
G01N 33/53, G01N 33/573, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15773468

METHODS FOR ENHANCING THE EFFICACY OF A TUMOR-DIRECTED IMMUNE RESPONSE

IPC classification:
A61K 39/39, A61P 37/02
Applicant:
Augusta University Research Institute, Inc.
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15777404

BISPECIFIC HER2 ANTIBODIES

IPC classification:
C07K 16/40, A61K 45/06, A61K 39/395
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15789548

MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF

IPC classification:
C07H 21/04, C07K 16/00, C12P 21/08, A61K 39/40, A61K 39/00
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15725113

PROCESSES FOR THE PREPARATION OF AZD5363 AND NOVEL INTERMEDIATE USED THEREIN

IPC classification:
C07D 498/10, C07D 487/04
Applicant:
AstraZeneca AB
Agent:
AstraZeneca PLC
Agent:
Mark David Ness, AstraZeneca AB
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15771960

ANTIBODIES TO TICAGRELOR AND METHODS OF USE

IPC classification:
C07D 487/04, C07K 16/44
Applicant:
MedImmune Limited
Agent:
Cooley (UK) LLP
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Agent:
AstraZeneca PLC
Status:
Request for examination was made
EP15827277

METHODS AND THERAPEUTIC COMBINATIONS FOR TREATING TUMORS

IPC classification:
A61P 35/00, A61K 39/39, C07D 471/04, A61K 31/437
Applicant:
3M Innovative Properties Company
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Agent:
AstraZeneca PLC
Status:
Request for examination was made

Please Sign in to use this feature